Skip to main content

COVID 19 Updates from RheumNow

Social

Today, the 5 most vaccinated states (14M people) had 580 people in hospital, 12 deaths In the 5 least vaccinated states (16M people)? 6,600 hospitalized, 104 deaths Per capita , least vaccinated states have 10X hospitalizations and 7X deaths So yeah, vaccines are working

Ashish K. Jha, MD, MPH @ashishkjha ( View Tweet )

2 years 8 months ago
Health personnel (HCP) @ long-term care facilities (LTCFs) are at high risk for COVID-19. March 2021, 57% of LTCF HCPs were vaccinated. COVID-19 vax was highest in MDs (75.1%); lowest nurses (56.7%) & aides (45.6%). https://t.co/VjHutcrh26 https://t.co/8aO1mFgC8f
Dr. John Cush @RheumNow ( View Tweet )
2 years 9 months ago
ICYMI: The FDA has authorized baricitinib ALONE as treatment for COVID-19 hospitalized adults and pediatric patients requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) https://t.co/WMc78GmOLU https://t.co/Bp5tL4pRk5
Dr. John Cush @RheumNow ( View Tweet )
2 years 9 months ago
Health personnel (HCP) @ long-term care facilities (LTCFs) are at high risk for COVID-19. March 2021, 57% of LTCF HCPs were vaccinated. COVID-19 vax was highest in MDs (75.1%); lowest nurses (56.7%) & aides (45.6%). https://t.co/VjHutcrh26

Dr. John Cush @RheumNow ( View Tweet )

2 years 9 months ago
The FDA has authorized baricitinib ALONE as treatment for COVID-19 hospitalized adults and pediatric patients requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) https://t.co/WMc78GmOLU

Dr. John Cush @RheumNow ( View Tweet )

2 years 9 months ago
Persistence of Sxs & Labs long after COVID. German study of 96 postCOVID pts followed 12 mos only 22% were Sx-free; Most had fatigue (53%), dyspnea (37%), concentration (40%), CNS (32%) & sleeping problems (26%), +ANA ≥1:160 in 44% https://t.co/L2ZzniDT18

Dr. John Cush @RheumNow ( View Tweet )

2 years 9 months ago
#VaccinationCovid DOES induce #SARS_CoV_2-specific #antibodies in #Rituximab-treated patients, after peripheral B-cells have at least partially repopulated! In addition, T cell responses (independent of B cell status) may also exert protective effects! https://t.co/E1FErHJtd3

Daniel Aletaha @DanielAletaha ( View Tweet )

2 years 9 months ago
Canakinumab Fails to Improve COVID-19 Survival https://t.co/ngThAgfHTq JAMA has published the findings of trial wherein the anti–interleukin-1β antibody canakinumab (CAN) failed to improve survival patients hospitalized with severe COVID-19. https://t.co/pUBmt85jAC
Dr. John Cush @RheumNow ( View Tweet )
2 years 9 months ago
152 Israeli pts w/ Breakthrough COVID infx >7d after 2nd Pfizer vax; all hospitalized, 38 w/ Poor outcome & 22% (34/152) died. All were older, most males, w/ comorbidities, 40% immunocompromised; high risk w/ RTX & low anti-spike IgG titers https://t.co/x1Uuyo7qim

Dr. John Cush @RheumNow ( View Tweet )

2 years 9 months ago
Vaccinated COVID-19 pts appear less contagious; report from Israel - among 650,000 received two-doses of Pfizer vaccine, 2,897 later tested positive for COVID-19, but nasal swab samples showed 4-fold less virus - hinting protection https://t.co/UBE4q5T2Ht https://t.co/OOgWoqdkdt
Dr. John Cush @RheumNow ( View Tweet )
2 years 9 months ago